Clinical Trial: SAR442168
This is a Phase 3, randomized, double-blind, 2-arm, placebo-controlled, parallel-group,
multicenter, trial to determine the efficacy of SAR442168 compared to placebo in delaying disability progression in primary progressive multiple sclerosis
Get Details